Page last updated: 2024-08-16

pioglitazone and dihydrotestosterone

pioglitazone has been researched along with dihydrotestosterone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CS; Ku, CY; Pinzone, JJ; Ringel, MD; Shiau, CW; Wei, S; Yang, CC1
Adachi, S; Baba, T; Endo, T; Fujibe, Y; Honnma, H; Ikeda, K; Kiya, T; Kuno, Y; Morishita, M; Nagao, S; Saito, T1

Other Studies

2 other study(ies) available for pioglitazone and dihydrotestosterone

ArticleYear
Peroxisome proliferator-activated receptor gamma-independent repression of prostate-specific antigen expression by thiazolidinediones in prostate cancer cells.
    Molecular pharmacology, 2006, Volume: 69, Issue:5

    Topics: Animals; Cell Line, Tumor; Dihydrotestosterone; Humans; Male; Pioglitazone; PPAR gamma; Prostate-Specific Antigen; Prostatic Neoplasms; Thiazolidinediones; Transfection

2006
Pioglitazone suppresses excessive follicular development in murine preantral follicles.
    Journal of ovarian research, 2019, Aug-31, Volume: 12, Issue:1

    Topics: Androgens; Animals; Bone Morphogenetic Protein 2; Dihydrotestosterone; Estradiol; Female; Hypoglycemic Agents; Mice, Inbred ICR; Ovarian Follicle; Pioglitazone; Vascular Endothelial Growth Factor A

2019
chemdatabank.com